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| INTRODUCTION
The American Cancer Society estimates that in 2018, about 42 220 adults (30 610 in men and 11 610 in women) in the United States will be diagnosed with primary liver cancer. 1 Liver is also a common site of metastases. 2, 3 Nearly 70-90% of liver metastases cannot be resected through surgery. 3 Stereotactic body radiotherapy (SBRT) has been shown to improve the local control rate of liver cancer.
Different from the conventional radiation therapy which uses low fractional dose of~2 Gy/fx, SBRT has a substantially greater cell-killing effect using very high fractional dose of 10-20 Gy/fx, 4, 5 leading to the excellent local tumor control rates of >90% if adequate radiation dose is delivered. 6 Sharp dose fall off outside the target volume
of SBRT requires precise contouring of target volume and organs at risk (OARs). 7, 8 Advanced imaging techniques, such as 4D-CT, are
commonly used for precise tumor volume contouring in SBRT.
Current liver SBRT technique is CT-based. However, CT is known to have low soft tissue contrast, and thus inability to accurately determine tumor volume and tumor motion in the abdomen. [9] [10] [11] [12] In current liver SBRT treatment planning, MRI is often fused to CT to assist target volume delineation. This approach is not ideal as the registration between CT and MRI is prone to errors, and large safety margin is often needed to compensate for this uncertainty, 13 which will increase the radiation dose to OARs. Therefore, current
CT-based liver SBRT treatment planning is ineffective and inefficient.
It requires multiple imaging scans (CT, multiple MRI, etc.) and additional planning efforts (CT-MRI registration, contour transfers, etc.), which increases the planning time, cost, and associated uncertainties.
There is a clear need for improved liver SBRT technology.
Compared to CT, MRI has many significant advantages for radiotherapy planning, including superior tumor and soft-tissue contrast, Axial T2 FRFSE, 3D CUBE T1, 3D CUBE T2, and 3D T1 3D SPGR.
The in-plane MRI distortions were calculated as the average of the distortion along the X and Y directions, and the through-plane distortions were calculated along the Z direction.
The simulated in-plane and through-plane MRI distortions, Disin(r1 ) and Dis thr (r 2 ) respectively, was obtained by fitting the sparsely measured in-plane and through-plane MRI distortions (Table 1 ) using a two-term exponential fitting model as shown in Eq. (1a) and (1b),
where r 1 is the radial distance from each pixel at in-plane image to the corresponding in-plane image center (x = 0, y = 0) and r 2 is the distance from each slice location to the central slice location (z = 0).
Then the radial distance r from each voxel to the scanning center (x = 0, y = 0, z = 0) and the 3D MRI distortion Dis sim (r) was then calculated as Eq. (2a) and (2b): 
Finally, a synthetic planning image dataset with simulated distortion was generated by deforming the original planning image dataset using the above-determined 3D MRI distortion.
2.B | 3D MRI distortion simulation based on body shrinkage
It was found from the above simulation study that meaningful anatomical changes due to MRI distortion mainly occur near the body surface. 17, 18 To efficiently evaluate the dosimetric effects due to different distortion magnitudes, we used a simple "body shrinkage" method to generate the distorted planning images by shrinking the body contour with a preset value (2, 3, 4, and 5 mm) centripetally in the Eclipse™ Treatment Planning System.
2.C | Dosimetric effects of MRI distortion in liver SBRT plan
Five clinical liver SBRT cases were included in this retrospective study. The planning CT images of the liver SBRT plans were used to generate simulated "distorted" CT planning images. For "distortion simulation" method, the simulated "distorted" CT planning images were generated by applying the MRI distortion (as a deformation field) onto the planning CT images via deformable image registration.
For "body shrinkage" method, the simulated "distorted" CT planning images were generated by shrinking the body contour with a preset value (2, 3, 4, and 5 mm). For each liver SBRT case, we then generated two MRI-based liver SBRT plans using the simulated "distorted"
CT planning images:
Plan A, in which the dose is calculated on the simulated "distorted" planning CT images using the original CT numbers. Plan A is used to determine the dosimetric effects solely caused by MRI distortion, assuming that the MRI images can be precisely converted to CT images without errors in CT number assignment.
Plan B, in which the dose is calculated on the simulated "distorted" planning CT images with each organ/structure assigned with an organ-specific CT number. This is to simulate a commonly-used method of MRI-to-CT conversion via CT number assignment. In our study, assuming that the distortion to organs is relatively small, we just consider the distortion to the body surface. Therefore, in Plan B the organ-specific CT number is assigned to structures of air, lungs and spine, which are contoured on the original CT images (without adding simulated distortion). The body structure needs to be recontoured after adding distortion and the soft tissue CT number is assigned to the new body structure. The organ-specific CT numbers were determined as the average CT numbers of the organ/structure from five liver SBRT cases: −850 HU for air, −700 HU for the lungs, 225 HU for spine, and 0 HU for soft-tissue. Plan B is used to determine the dosimetric effects caused jointly by MRI distortion and CT number assignment. GTV and PTV was 0.76 Gy and the maximum error percentage was 1.52%; for a prescription dose of 25 Gy, the maximum difference was 0.26 Gy and the maximum error percentage was 1.04%. And the differences in mean liver dose and liver V 30% were 0.11 Gy and 0.21%, respectively. The differences in other DVH parameters were also small (<0.1 Gy or <2.0%).
It can be observed from these results that: (a) dosimetric effects of MRI distortion on liver SBRT treatment plans are generally small, and (b) MRI-to-CT conversion using bulk CT number assignment tends to produce extra (but small) dosmetric uncertainties in addition to MRI distortion.
3.B | Dosimetric effects of MRI distortion simulated using "body shrinkage" method In this study, we investigated the dosimetric effects caused by MRI geometric distortion in a computer simulation study. In addition, since the lack of electron density information in MRI is the other major impediments for MRI-based treatment planning, we also considered the dosimetric effects caused by CT number assignment.
We tried to use a more realistic geometric distortion, but due to the chemical shift effect, different MR scanners and different vendor F I G . 4. Dosimetric uncertainties caused by MR geometric distortions simulation based on "body shrinkage" method.
correction algorithm, we cannot verify the effect of all distortions on the MRI-based treatment planning dose calculation. We simulated MR geometric distortion based on the measured distortion on a phantom scanned with a GE 1.5T MR-SIM scanner. The distortion difference caused by different scanning machine and different patients cannot be evaluated and considered in this study.
For MR geometric distortion simulation from "body shrinkage" method, we consider the distortion at the surface of the body. It was found that the largest distortion occurs at the surface of the body, the organs inside the body still have distortion. If the tumor is closer to the center of the image, the distortion can be neglected.
However, if the tumor is closer to the surface, due to the distortion, a larger margin may need to be considered for GTV contouring. For MR geometric distortion simulation based on measured distortion data, the distortion is added to both the body surface and the organs. However, in dose calculation, we did not recontour the organ structures since we wanted to compare the dose difference by minimizing the dose difference caused by the structure contouring uncertainties. In this approach, we did not consider the distortion of the organs in dose calculation. limitations of 4D-CT in abdominal imaging. 22, 23 Future studies need to be performed on 4D MRI-based treatment planning for liver SBRT to investigate the dosimetric uncertainties caused by geometric distortion and CT number assignment.
| CONCLUSION
We performed simulation study of dosimetric effects from MRI distortion on liver SBRT plans. It was found that dose uncertainties caused by MR distortion was generally small (<1 Gy), for various DVH parameters. These results may indicate that it is dosimetrically acceptable to perform MRI solely based treatment planning for liver SBRT despite uncertainties in residual MRI distortion and CT number assignment.
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